BMAL2 and pancreatic adenocarcinoma: A total of 10 NRGs were identified as independent PAAD prognostic markers (MET, CASKIN2, TLE2, USP20, MROH9, SPRN, ARSG, ARNTL2, ANLN, LY6D; Figure 5A).